Visanu Wanchai

Instructor

UAMS

Last publication 2026 Last refreshed 2026-05-23

faculty

Biomedical Informatics, College of Medicine

visanu.wanchai@gmail.com

15 h-index 49 pubs 966 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Visanu Wanchai's research interests include the genomic analysis of various organisms and the study of disease mechanisms. His work has involved investigating the genetic makeup of bacteria, such as Escherichia coli, and identifying distinct phylogroups. Wanchai has also contributed to understanding viral genomes, examining the genetic repertoire of SARS-CoV-2 during different pandemic waves and comparing Monkeypox virus genomes from distinct outbreaks.

Furthermore, his research extends to cancer biology, with studies focusing on multiple myeloma. This includes investigating immune microenvironment alterations in multiple myeloma and its precursor stages, as well as exploring the efficacy of bispecific CAR-T cells in controlling myeloma growth. Wanchai's work also touches upon cellular biology, including the refinement of mesenchymal cell types associated with murine bone structures and transcriptomic analysis using native RNA or cDNA sequencing.

Metrics

h-index: 15
Publications: 49
Citations: 966

Selected Publications

An Enhancement of Extrachromosomal Circular DNA Enrichment and Amplification to Address the Extremely Low Overlap Between Replicates (2026)

DOI OpenAlex
Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength (2025)

5 citations DOI OpenAlex
An Enhancement of Extrachromosomal Circular DNA Enrichment and Amplification to Address the Extremely Low Overlap Between Replicates (2025)

DOI OpenAlex
Single Nuclei Multiomic Profiling of Transcriptional and Chromatin Accessibility of Tumor Cells Underlines Extensive Cis-Regulatory Interaction during Multiple Myeloma Progression (2024)

DOI OpenAlex
Multi-Omics Reveal Immune Microenvironment Alterations in Multiple Myeloma and Its Precursor Stages (2024)

1 citation DOI OpenAlex
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages (2024)

22 citations DOI OpenAlex
DNA structural features and variability of complete MHC locus sequences (2024)

6 citations DOI OpenAlex
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation (2024)

4 citations DOI OpenAlex
Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone (2024)

23 citations DOI OpenAlex
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth (2024)

33 citations DOI OpenAlex
A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone (2023)

1 citation DOI OpenAlex
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma (2023)

17 citations DOI OpenAlex
A gene signature can predict risk of MGUS progressing to multiple myeloma (2023)

13 citations DOI OpenAlex
A Gene Signature Can Predict Risk of MGUS Progressing to Multiple Myeloma (2023)

DOI OpenAlex
A 12 Gene Signature Accurately Predicts Multiple Myeloma Progression from Monoclonal Gammopathy of Undetermined Significance (2022)

DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator
Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator
Project 1 – Prevention of MGUS progression to MM by modulating the bone marrow microenvironment NIH/Nat. Cancer Institute - Pass Through: Baylor College of Medicine Principal Investigator